Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

NPCE

+ Watchlist+ Portfolio

Neuropace, Inc.

Regulated industryPhysical productsTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$8.20
52-Week Range
$5.46 – $19.60
Market Cap
$283.19M
P/E (TTM)
—
EPS (TTM)
-0.56
Dividend Yield
0.00%
Advanced Metrics
Price/Book
24.61
PEG Ratio
—
Return on Equity
-96.97%
Return on Assets
-6.31%
Gross Margin
77.84%
Operating Margin
-9.55%
Profit Margin
-17.72%
Current Ratio
5.26
Debt/Equity
6.05
Total Debt
$69.54M
Free Cash Flow
$-2.41M
Revenue Growth
-1.10%
Earnings Growth
—
Enterprise Value
$303.50M

Market Snapshot

About

Neuropace develops and commercializes the RNS System, a brain-responsive neurostimulation device for treating drug-resistant focal epilepsy through personalized, closed-loop therapy.